Clinical Trial Update: Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of Rare Advanced Tumors [Phase 2]

View source ↗

Summary

Phase II, multi-cohort, single-arm trial evaluating a triplet regimen of albumin-bound paclitaxel, ifosfamide, and cisplatin in rare advanced tumors. The study,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extramammary Paget Disease
• Penile Cancer
• Rhabdomyosarcoma
• Testicular Cancer
• Urachal Cancer

Drugs mentioned

• Albumin Paclitaxel (nab-paclitaxel)
• CISPLATIN (cisplatin)
• IFOSFAMIDE (IFOSFAMIDE)

Snippet

Sponsor: Fudan University | Conditions: Paget Disease, Extramammary, Rhabdomyosarcoma | Phase 2 | Status: RECRUITING